Literature DB >> 23893132

Structural basis for the inhibition of Polo-like kinase 1.

Jun Xu1, Chen Shen, Tao Wang, Junmin Quan.   

Abstract

Polo-like kinase 1 (PLK1) is a master regulator of mitosis and is considered a potential drug target for cancer therapy. PLK1 is characterized by an N-terminal kinase domain (KD) and a C-terminal Polo-box domain (PBD). The KD and PBD are mutually inhibited, but the molecular mechanisms of the autoinhibition remain unclear. Here we report the 2.3-Å crystal structure of the complex of the Danio rerio KD and PBD together with a PBD-binding motif of Drosophila melanogaster microtubule-associated protein 205 (Map205(PBM)). The structure reveals that the PBD binds and rigidifies the hinge region of the KD in a distinct conformation from that of the phosphopeptide-bound PBD. This structure provides a framework for understanding the autoinhibitory mechanisms of PLK1 and also sheds light on the activation mechanisms of PLK1 by phosphorylation or phosphopeptide binding.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23893132     DOI: 10.1038/nsmb.2623

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  54 in total

1.  Complex formation of Plk1 and INCENP required for metaphase-anaphase transition.

Authors:  Hidemasa Goto; Tohru Kiyono; Yasuko Tomono; Aie Kawajiri; Takeshi Urano; Koichi Furukawa; Erich A Nigg; Masaki Inagaki
Journal:  Nat Cell Biol       Date:  2005-12-25       Impact factor: 28.824

Review 2.  Polo-like kinases: conservation and divergence in their functions and regulation.

Authors:  Vincent Archambault; David M Glover
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

3.  Analysis of temperature factor distribution in high-resolution protein structures.

Authors:  S Parthasarathy; M R Murthy
Journal:  Protein Sci       Date:  1997-12       Impact factor: 6.725

4.  Crystal structure of the Src family tyrosine kinase Hck.

Authors:  F Sicheri; I Moarefi; J Kuriyan
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

Review 5.  Polo-like kinases and oncogenesis.

Authors:  Frank Eckerdt; Juping Yuan; Klaus Strebhardt
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

6.  The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.

Authors:  Kin-Yip Cheng; Edward D Lowe; John Sinclair; Erich A Nigg; Louise N Johnson
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

7.  Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.

Authors:  Sang-Moon Yun; Tinoush Moulaei; Dan Lim; Jeong K Bang; Jung-Eun Park; Shilpa R Shenoy; Fa Liu; Young H Kang; Chenzhong Liao; Nak-Kyun Soung; Sunhee Lee; Do-Young Yoon; Yoongho Lim; Dong-Hee Lee; Akira Otaka; Ettore Appella; James B McMahon; Marc C Nicklaus; Terrence R Burke; Michael B Yaffe; Alexander Wlodawer; Kyung S Lee
Journal:  Nat Struct Mol Biol       Date:  2009-07-13       Impact factor: 15.369

8.  Structural basis for the autoinhibition of c-Abl tyrosine kinase.

Authors:  Bhushan Nagar; Oliver Hantschel; Matthew A Young; Klaus Scheffzek; Darren Veach; William Bornmann; Bayard Clarkson; Giulio Superti-Furga; John Kuriyan
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

9.  Cdk1 phosphorylation of BubR1 controls spindle checkpoint arrest and Plk1-mediated formation of the 3F3/2 epitope.

Authors:  Oi Kwan Wong; Guowei Fang
Journal:  J Cell Biol       Date:  2007-11-12       Impact factor: 10.539

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  47 in total

Review 1.  Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.

Authors:  Kyung S Lee; Terrence R Burke; Jung-Eun Park; Jeong K Bang; Eunhye Lee
Journal:  Trends Pharmacol Sci       Date:  2015-10-17       Impact factor: 14.819

2.  The methyltransferase SETD6 regulates Mitotic progression through PLK1 methylation.

Authors:  Michal Feldman; Zlata Vershinin; Inna Goliand; Natalie Elia; Dan Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-08       Impact factor: 11.205

3.  Autoinhibition and relief mechanism for Polo-like kinase 4.

Authors:  Joseph E Klebba; Daniel W Buster; Tiffany A McLamarrah; Nasser M Rusan; Gregory C Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

4.  Unique subcellular distribution of phosphorylated Plk1 (Ser137 and Thr210) in mouse oocytes during meiotic division and pPlk1(Ser137) involvement in spindle formation and REC8 cleavage.

Authors:  Juan Du; Yan Cao; Qian Wang; Nana Zhang; Xiaoyu Liu; Dandan Chen; Xiaoyun Liu; Qunyuan Xu; Wei Ma
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 5.  Understanding the Polo Kinase machine.

Authors:  V Archambault; G Lépine; D Kachaner
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

6.  Cdk1 plays matchmaker for the Polo-like kinase and its activator SPAT-1/Bora.

Authors:  Nicolas Tavernier; Costanza Panbianco; Monica Gotta; Lionel Pintard
Journal:  Cell Cycle       Date:  2015-06-03       Impact factor: 4.534

7.  Identification of Polo-like kinase 1 interaction inhibitors using a novel cell-based assay.

Authors:  Karine Normandin; Jean-François Lavallée; Marie Futter; Alexandre Beautrait; Jean Duchaine; Sébastien Guiral; Anne Marinier; Vincent Archambault
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

8.  Several inhibitors of the Plk1 Polo-Box Domain turn out to be non-specific protein alkylators.

Authors:  Vincent Archambault; Karine Normandin
Journal:  Cell Cycle       Date:  2017-05-19       Impact factor: 4.534

9.  Polo-like Kinase 1 Regulates Vimentin Phosphorylation at Ser-56 and Contraction in Smooth Muscle.

Authors:  Jia Li; Ruping Wang; Olivia J Gannon; Alyssa C Rezey; Sixin Jiang; Brennan D Gerlach; Guoning Liao; Dale D Tang
Journal:  J Biol Chem       Date:  2016-09-23       Impact factor: 5.157

Review 10.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.